How does the canadian general public rate moderate Alzheimer's disease?
- PMID: 22229093
- PMCID: PMC3250621
- DOI: 10.4061/2011/682470
How does the canadian general public rate moderate Alzheimer's disease?
Abstract
Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the health utility score for respondents' current health status (i.e., no AD) and for a hypothetical moderate AD health state. Regression analyses were conducted to explain the perceived utility decrement associated with AD. Results. The mean age of the respondents was 51 years, 60% were female, and 42% knew someone with AD. Respondents' mean EQ-5D scores for their current health status and a hypothetical moderate AD were 0.873 (SD: 0.138) and 0.638 (SD: 0.194), respectively (P < 0.001). Age, gender, and education were significant factors explaining this decrement in utility. Conclusion. Members of the general public may serve as an alternative to patients and caregivers in the elicitation of health-related quality of life in AD.
Figures
Similar articles
-
A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.Health Qual Life Outcomes. 2016 Jul 18;14(1):105. doi: 10.1186/s12955-016-0510-y. Health Qual Life Outcomes. 2016. PMID: 27431327 Free PMC article.
-
Can the general public use vignettes to discriminate between Alzheimer's disease health states?BMC Geriatr. 2016 Feb 3;16:36. doi: 10.1186/s12877-016-0207-4. BMC Geriatr. 2016. PMID: 26842500 Free PMC article.
-
Measuring health-related quality-of-life for Alzheimer's disease using the general public.Qual Life Res. 2012 May;21(4):593-601. doi: 10.1007/s11136-011-9966-8. Epub 2011 Jul 9. Qual Life Res. 2012. PMID: 21744032 Clinical Trial.
-
Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights.Value Health. 2014 Jan-Feb;17(1):77-83. doi: 10.1016/j.jval.2013.10.009. Value Health. 2014. PMID: 24438720
-
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.Qual Life Res. 2005 Aug;14(6):1523-32. doi: 10.1007/s11136-004-7713-0. Qual Life Res. 2005. PMID: 16110932 Review.
Cited by
-
A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.Health Qual Life Outcomes. 2016 Jul 18;14(1):105. doi: 10.1186/s12955-016-0510-y. Health Qual Life Outcomes. 2016. PMID: 27431327 Free PMC article.
References
-
- Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. National Vital Statistics Reports. 2009;57(14):1–134. - PubMed
-
- Alzheimer’s Association. Early Onset Dementia: A National Challenge, a Future Crisis. Washington, DC, USA: Alzheimer’s Association; 2006.
-
- Alzheimer’s Association. 2009 Alzheimer’s disease facts and figures. Alzheimers Dement. 2009;5(3):234–270. - PubMed
-
- Alzheimer’s Association. Saving Lives. Saving Money: Dividends for Americans Investing in Alzheimer Research. Report of the Lewin Group to the Alzheimer’s Association. Washington, DC, USA: Alzheimer’s Association; 2004.
-
- Bloom BS, de Pouvourville N, Straus WL. Cost of illness of Alzheimer’s disease: how useful are current estimates? Gerontologist. 2003;43(2):158–164. - PubMed
LinkOut - more resources
Full Text Sources